Description
Title: Lariago – Antimalarial Treatment for Malaria
Description:
Lariago is an antimalarial medication that contains Chloroquine Phosphate. It is primarily used to treat and prevent malaria by eliminating the parasites responsible for the disease.
Contents:
Chloroquine Phosphate IP
Uses:
Lariago is indicated for:
Treatment of malaria caused by Plasmodium species.
Prevention of malaria in individuals traveling to endemic areas.
Side Effects:
Common Side Effects:
Headache
Nausea and Vomiting
Abdominal cramps
Rashes and Itching
Serious Side Effects:
Abnormal blood cell counts
Allergic reactions
Hypoglycemia (abnormal fall in blood sugar levels)
Precautions:
Not suitable for individuals with known allergies to chloroquine.
Consult a doctor if pregnant, planning a pregnancy, or breastfeeding.
Use with caution in patients with liver, kidney, or heart disorders.
Directions for Use:
Take Lariago as prescribed by your healthcare provider.
It is recommended to take the tablet with food to minimize gastrointestinal discomfort.
HSN Code:
3004, categorizing it under antimalarial pharmaceuticals.
There are no reviews yet.